Mensura Health, Inc. is an early-stage company dedicated to finding practical solutions for rapid and accurate therapeutic drug monitoring (TDM) of small molecule drug levels at the point of care (PoC). In diseases where TDM in patients can dramatically improve the effectiveness of existing medications, the availability of highly accurate, rapid PoC options can greatly contribute to amelioration of morbidity and dramatic improvements in quality of life for patients. The initial focus of the company is on epilepsy. Mensura Health, Inc., was founded several years ago by a small group of academic, biotech industry and finance professionals dedicated to improving PoC TDM. Our detection platform employs electrochemical-based biosensors using cutting-edge aptamer technology.